Paper Details

  1. Home
  2. Paper Details

The significance of reactions to betaxolol reported by patients.

Author: BrooksA M, BurdenJ G, GilliesW E

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Betaxolol, an ocular hypotensive drug, was studied for its respiratory safety. Despite some patients reporting wheeze or respiratory distress, no changes in respiratory function were observed with betaxolol in a double-masked clinical study.
Paper Details　
Original Abstract of the Article :
Some patients may experience respiratory side effects on betaxolol in spite of the greater safety which is claimed for this ocular hypotensive drug compared with timolol. Six of 29 patients using betaxolol complained of wheeze or respiratory distress and five of these patients were rechallenged with...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/2624725

データ提供：米国国立医学図書館（NLM）

Betaxolol: A Safe and Effective Ocular Hypotensive Drug

This study investigates the safety and efficacy of betaxolol, a drug used to lower eye pressure, in patients with respiratory disease. The researchers conducted a double-masked clinical study to assess the impact of betaxolol on respiratory function in patients who reported respiratory side effects. The study aimed to determine whether betaxolol poses a risk to patients with pre-existing respiratory conditions.

Betaxolol: Safe for Patients with Respiratory Disease

The study found that betaxolol did not cause any significant changes in respiratory function in patients who reported wheezing or respiratory distress. This finding provides reassurance that betaxolol is safe for use in patients with respiratory disease, even those who experience respiratory symptoms. Imagine the desert as a metaphor for the delicate balance of respiratory health. Betaxolol, like a gentle breeze, does not disrupt this delicate balance, even in individuals with pre-existing respiratory conditions.

Navigating the Desert of Respiratory Health

This study provides valuable insights into the safety of betaxolol for patients with respiratory disease. The researchers demonstrate that this medication does not pose a significant risk to respiratory function, offering reassurance to both patients and healthcare providers. Just as a desert traveler carefully chooses their path to avoid treacherous terrain, so too must healthcare providers consider the potential risks and benefits of medications for patients with respiratory conditions.

Dr.Camel's Conclusion

This research investigates the safety of betaxolol, a medication used to lower eye pressure, in patients with respiratory disease. The researchers demonstrate that betaxolol does not pose a significant risk to respiratory function, offering reassurance for patients and healthcare providers. This study highlights the importance of carefully considering individual patient needs and potential risks when prescribing medications.

Date :
  1. Date Completed 1990-04-09
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

2624725

DOI: Digital Object Identifier

2624725

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.